Cell Biol Toxicol (2010) 26:1–20 type 2, 4, and 5 vectors: transduction of variant cell types and regions in the mammalian central nervous system. Proc Natl Acad Sci USA. 2000;97:3428–32. Davison E, Kirby I, Whitehouse J, Hart I, Marshall JF, Santis G. Adenovirus type 5 uptake by lung adenocarcinoma cells in culture correlates with Ad5 fibre binding is mediated by alpha(v)beta1 integrin and can be modulated by changes in beta1 integrin function. J Gene Med. 2001;3:550–9. Daya S, Berns KI. Gene therapy using adeno-associated virus vectors. Clin Microbiol Rev. 2008;21:583–93. De Rijck J, Van MB, Debyser Z. Positional effects of the central DNA flap in HIV-1-derived lentiviral vectors. Biochem Biophys Res Commun. 2005;328:987–94. Dedieu JF, Vigne E, Torrent C, Jullien C, Mahfouz I, Caillaud JM, et al. Long-term gene delivery into the livers of immuno- competent mice with E1/E4-defective adenoviruses. J Virol. 1997;71:4626–37. Delenda C. Lentiviral vectors: optimization of packaging, transduction and gene expression. J Gene Med. 2004;6 (Suppl 1):S125–38. DePolo NJ, Reed JD, Sheridan PL, Townsend K, Sauter SL, Jolly DJ, et al. VSV-G pseudotyped lentiviral vector particles produced in human cells are inactivated by human serum. Molec Ther. 2000;2:218–22. Dmitriev I, Kashentseva E, Rogers BE, Krasnykh V, Curiel DT. Ectodomain of coxsackievirus and adenovirus receptor genetically fused to epidermal growth factor mediates adenovirus targeting to epidermal growth factor receptor- positive cells. J Virol. 2000;74:6875–84. Dormitzer PR, Sun ZY, Blixt O, Paulson JC, Wagner G, Harrison SC. Specificity and affinity of sialic acid binding by the rhesus rotavirus VP8* core. J Virol. 2002;76:10512–7. Dull T, Zufferey R, Kelly M, Mandel RJ, Nguyen M, Trono D, et al. A third-generation lentivirus vector with a condi- tional packaging system. J Virol. 1998;72:8463–71. Engelhardt JF, Ye X, Doranz B, Wilson JM. Ablation of E2A in recombinant adenoviruses improves transgene persistence and decreases inflammatory response in mouse liver. Proc Natl Acad Sci USA. 1994;91:6196–200. Epstein AL. HSV-1-based amplicon vectors: design and applications. Gene Ther. 2005;12(Suppl 1):S154–8. Farley DC, Brown JL, Leppard KN. Activation of the early-late switch in adenovirus type 5 major late transcription unit expression by L4 gene products. J Virol. 2004;78:1782–91. Ferrari G, Salvatori G, Rossi C, Cossu G, Mavilio F. A retroviral vector containing a muscle-specific enhancer drives gene expression only in differentiated muscle fibers. Hum Gene Ther. 1995;6:733–42. Fleischli C, Sirena D, Lesage G, Havenga MJ, Cattaneo R, Greber UF, et al. Species B adenovirus serotypes 3, 7, 11 and 35 share similar binding sites on the membrane cofactor protein CD46 receptor. J Gen Virol. 2007;88:2925–34. Frankel AD, Young JA. HIV-1: fifteen proteins and an RNA. Annu Rev Biochem. 1998;67:1–25. Fu H, Muenzer J, Samulski RJ, Breese G, Sifford J, Zeng X, et al. Self-complementary adeno-associated virus serotype 2 vector: global distribution and broad dispersion of AAV- mediated transgene expression in mouse brain. Molec Ther. 2003;8:911–7. Gallay P, Hope T, Chin D, Trono D. HIV-1 infection of nondividing cells through the recognition of integrase by 15 the importin/karyopherin pathway. Proc Natl Acad Sci USA. 1997;94:9825–30. Gao GP, Alvira MR, Wang L, Calcedo R, Johnston J, Wilson JM. Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy. Proc Natl Acad Sci USA. 2002;99:11854–9. Georgievska B, Jakobsson J, Persson E, Ericson C, Kirik D, Lundberg C. Regulated delivery of glial cell line- derived neurotrophic factor into rat striatum, using a tetracycline-dependent lentiviral vector 1. Hum Gene Ther. 2004;15:934–44. Glorioso JC, Fink DJ. Herpes vector-mediated gene transfer in the treatment of chronic pain. Molec Ther. 2009;17: 13–8. Glover CP, Bienemann AS, Heywood DJ, Cosgrave AS, Uney JB. Adenoviral-mediated, high-level, cell-specific trans- gene expression: a SYN1-WPRE cassette mediates in- creased transgene expression with no loss of neuron specificity. Molec Ther. 2002;5:509–16. Glover CP, Bienemann AS, Hopton M, Harding TC, Kew JN, Uney JB. Long-term transgene expression can be mediated in the brain by adenoviral vectors when powerful neuron- specific promoters are used. J Gene Med. 2003;5:554–9. Graham FL, Smiley J, Russell WC, Nairn R. Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J Gen Virol. 1977;36:59–74. Greber UF, Suomalainen M, Stidwill RP, Boucke K, Ebersold MW, Helenius A. The role of the nuclear pore complex in adenovirus DNA entry. EMBO J. 1997;16:5998– 6007. Hacein-Bey-Abina S, Von KC, Schmidt M, McCormack MP, Wulffraat N, Leboulch P, et al. LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science. 2003;302:415–9. Harding TC, Geddes BJ, Noel JD, Murphy D, Uney JB. Tetracycline-regulated transgene expression in hippocam- pal neurones following transfection with adenoviral vectors. J Neurochem. 1997;69:2620–3. Harding TC, Geddes BJ, Murphy D, Knight D, Uney JB. Switching transgene expression in the brain using an adenoviral tetracycline-regulatable system. Nat Biotech- nol. 1998;16:553–5. Horwood NJ, Smith C, Andreakos E, Quattrocchi E, Brennan F, Feldmann M, et al. High efficiency gene transfer into nontransformed cells: utility for studying gene regulation and analysis of potential therapeutic targets. Arthritis Research and Therapy. 2002;4(suppl 3):S215–225. Havenga MJ, Lemckert AA, Ophorst OJ, van MM, Germeraad WT, Grimbergen J, et al. Exploiting the natural diversity in adenovirus tropism for therapy and prevention of disease. J Virol. 2002;76:4612–20. He TC, Zhou S, da Costa LT, Yu J, Kinzler KW, Vogelstein B. A simplified system for generating recombinant adenovi- ruses. Proc Natl Acad Sci USA. 1998;95:2509–14. Heinzinger NK, Bukinsky MI, Haggerty SA, Ragland AM, Kewalramani V, Lee MA, et al. The Vpr protein of human immunodeficiency virus type 1 influences nuclear locali- zation of viral nucleic acids in nondividing host cells. Proc Natl Acad Sci USA. 1994;91:7311–5. Hermens WT, Verhaagen J. Viral vectors, tools for gene transfer in the nervous system. Prog Neurobiol. 1998;55:399–432.